The Clinical Efficacy and Safety of ErhBMP ‐2/ BioCaP /β‐ TCP as a Novel Bone Substitute Using the Tooth‐Extraction‐Socket‐Healing Model: A Proof‐of‐Concept Randomized Controlled Trial
Journal of Clinical Periodontology · 2025-02 · 52 (2) · 299-309
DOI: 10.1111/jcpe.14084 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Periodontology, online erschienen am 31.10.2024. Verfasst von Lingfei Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Second Dental Center, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shang…. Hauptthemen laut MEDLINE: Calcium Phosphates, Bone Substitutes, Bone Morphogenetic Protein 2, Tooth Socket. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, ZonMW Project, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Aim
This first randomized controlled trial in humans aimed to assess the efficacy and safety of low‐dosage Escherichia coli ‐derived recombinant human bone morphogenetic protein 2 (ErhBMP‐2)‐incorporated biomimetic calcium phosphate coating‐functionalized β‐TCP (ErhBMP‐2/BioCaP/β‐TCP) as a novel bone substitute using the tooth‐extraction‐socket‐healing model. Materials and Methods Forty patients requiring dental implants after single‐root tooth extraction were enrolled in this study and randomly assigned into three groups: ErhBMP‐2/BioCaP/β‐TCP ( N = 15), β‐TCP ( N = 15) and natural healing ( N = 10). New bone volume density from histomorphometric analyses was evaluated 6 weeks post‐operatively as the primary outcome, and other histomorphometric analyses, alveolar bone and soft‐tissue changes were the secondary outcomes. Safety parameters included adverse events, soft‐tissue healing, oral health impact profile, serum BMP‐2 concentrations and other laboratory tests.
Results
The findings revealed a significant increase in new bone volume density in patients treated with ErhBMP‐2/BioCaP/β‐TCP compared to those receiving β‐TCP alone. The required bone augmentation procedures during implant placement surgery in the ErhBMP‐2/BioCaP/β‐TCP group were significantly less than in the natural healing group. There were no significant differences in safety parameters among the three groups.
Conclusion
This clinical trial primarily proved the safety and efficacy of ErhBMP‐2/BioCaP/β‐TCP as a promising bone substitute.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Second Dental Center, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Cl…
- Department of Oral Cell Biology, Academic Centre for Dentistry Amsterdam (ACTA), Vrije Universiteit Amsterdam and University of Amsterdam, Amsterdam, The Netherlands.
- Department of Oral Implantology, Yantai Stomatological Hospital, Binzhou Medical University, Yantai, China.
- Profess Medical Consultancy BV, Heerhugowaard, The Netherlands.
- TPE, Private Practice, Ellecom, The Netherlands.
ORCID-Profile: Lingfei Wei, Yuelian Liu
Förderung
- National Natural Science Foundation of China
- ZonMW Project
- Natural Science Foundation of Shandong Province
- Natural Science Foundation of Yantai
- Shanghai Clinical Research Center for Oral Diseases
- Shanghai Municipal Key Clinical Specialty
- Shanghai's Top Priority Research Center
- CAMS Innovation Fund for Medical Sciences (CIFMS)
Zitieren
APA
Wei, L., Sun, Y., Yu, D., Pieterse, H., Wismeijer, D., Liu, Y., & Wu, Y. (2025). The Clinical Efficacy and Safety of ErhBMP ‐2/ BioCaP /β‐ TCP as a Novel Bone Substitute Using the Tooth‐Extraction‐Socket‐Healing Model: A Proof‐of‐Concept Randomized Controlled Trial. Journal of Clinical Periodontology, 52(2), 299-309. https://doi.org/10.1111/jcpe.14084
Vancouver
Wei L, Sun Y, Yu D, Pieterse H, Wismeijer D, Liu Y, et al. The Clinical Efficacy and Safety of ErhBMP ‐2/ BioCaP /β‐ TCP as a Novel Bone Substitute Using the Tooth‐Extraction‐Socket‐Healing Model: A Proof‐of‐Concept Randomized Controlled Trial. Journal of Clinical Periodontology. 2025;52(2):299-309. doi:10.1111/jcpe.14084
BibTeX
@article{Wei2025,
author = {Wei, Lingfei and Sun, Yuanyuan and Yu, Dedong and Pieterse, Herman and Wismeijer, Daniel and Liu, Yuelian and Wu, Yiqun},
title = {The Clinical Efficacy and Safety of ErhBMP ‐2/ BioCaP /β‐ TCP as a Novel Bone Substitute Using the Tooth‐Extraction‐Socket‐Healing Model: A Proof‐of‐Concept Randomized Controlled Trial},
journal = {Journal of Clinical Periodontology},
year = {2025},
volume = {52},
number = {2},
pages = {299--309},
doi = {10.1111/jcpe.14084}
}
EUVIMED